Open AccessMedical Treatment in Spinal Cord Injury
Author(s) -
Halil Can,
Eyüp Cab Savrunlu,
Serdar Kabataş
Publication year - 2021
Publication title -
sinir sistemi cerrahisi dergisi
Language(s) - English
Resource type - Journals
ISSN - 1306-4126
DOI - 10.5222/sscd.2021.80764
Subject(s) - medicine , spinal cord , spinal cord injury , neuroprotection , randomized controlled trial , clinical trial , cord , anesthesia , physical therapy , intensive care medicine , physical medicine and rehabilitation , surgery , pathology , psychiatry
Spinal cord injuries cause psychological in humans and require expensive care and treatments. In recent years, various pharmacological agents have been tested in acute spinal cord injuries. Prospective randomized controlled clinical trials on a large scale have failed to demonstrate significant neurological progression, in contrast to their success in the laboratory. The search for an effective neuroprotective pharmacological agent to prevent secondary damage in acute spinal cord injuries remains primary goals for basic sciences and clinicians.